A $49 virtual visit that replaces a $150 trip to the doctor’s office. It’s the kind of math that makes CFOs smile and benefits teams look like heroes. And if you’ve been around self-funded plans long enough, you already suspect the truth. The real cost isn’t in that first visit. It’s in everything that comes next.
I’ve watched this pattern unfold across dozens of renewal cycles. The telehealth vendor reports massive per-visit savings, the utilization dashboard lights up green, and twelve months later the stop-loss carrier flags a 4% jump in specialty and imaging spend. Nobody connects the dots. That’s the telemedicine cost paradox-a phenomenon plan actuaries track quietly, but one that rarely finds its way into the boardroom.
The Visit Is Cheap. The Episode Is Not.
Almost every telemedicine ROI model compares a virtual urgent care claim ($40-$70) against an in-person office visit ($100-$200) or an emergency department trip ($1,200+). On paper, the per-unit savings look undeniable. But that comparison is clinically blind. It ignores what happens when a doctor who can’t touch a patient decides to order a test “just to rule something out.”
Picture a 42-year-old employee with a nagging cough. He opens a telehealth app, spends $49, and describes his symptoms. The virtual physician, unable to listen to his lungs, orders a chest X-ray and refers him to a pulmonologist. Within a week, the episode includes a $280 radiology claim, a $350 specialist consult, and a $2,000 bronchoscopy. That initial visit didn’t replace primary care-it bypassed it entirely, multiplying the cost of the episode by seven to ten times. The plan would have been better off with a $25 PCP copay and a watchful waiting conversation.
This isn’t a rare chain of events. A massive RAND study of over 500,000 commercially insured lives found that only 12% of telemedicine visits actually substituted for an in-person encounter. The other 88% were new utilization-care that wouldn’t have been sought otherwise. When researchers tallied the total cost, they discovered an increase of roughly $45 per member per month. Over a 10,000-life plan, that’s an extra $5.4 million a year flowing out the back door while leadership celebrates the per-visit savings.
When Free Care Fuels Overuse
The economics break down the moment we treat telemedicine like a limitless, pre-paid benefit. Most employers have zero-copay virtual visits, often bolted on through a point solution that sits outside the core carrier. It’s frictionless and free at the point of service-exactly the kind of design that behavioral economists warn against.
Here’s the trouble: when there’s no cost-share, moral hazard spikes. Members who might have given a symptom another day, messaged their PCP, or self-resolved initiate a claim the instant something feels off. The deductible, normally the strongest lever against low-value utilization, gets bypassed. And thanks to the CARES Act and permanent IRS safe harbors, high-deductible health plans with HSAs can now cover telemedicine before the deductible is met. That was a well-intentioned pandemic-era flexibility, but it created a structural escape hatch-virtual care becomes the one place in the plan where consumerism never takes hold.
What’s more, during open enrollment, telemedicine is almost always framed as a “free additional benefit.” That word-“free”-is incredibly powerful. Behavioral design tells us it primes overuse. Something as simple as a $15-$25 copay could trim low-acuity visits by 20-30% without putting a meaningful barrier in front of necessary care.
The Hidden Tax of Going It Alone
Beyond the behavioral incentives, there’s a technical fragmentation that most procurement processes never evaluate. Telemedicine is often a standalone app with its own network, its own eligibility file, and its own claims stream that never touches your plan’s core clinical ecosystem. The price of that disconnection shows up in several quiet ways.
- No longitudinal record. A virtual visit for headaches doesn’t appear in the care management platform. The nurse navigator assigned to that member has no idea it happened. A week later, the same member ends up in the ER for a scan that targeted primary care could have prevented.
- Duplicate diagnostics. The telehealth provider can’t see the patient’s claims history or recent labs. So they order tests that were already completed months ago, layering new spending on top of old.
- Network leakage. Self-insured employers pour resources into high-performance networks and centers of excellence. But when a virtual visit triggers a referral, it almost always defaults to a broad-network provider. The plan’s steerage logic is completely bypassed.
I’ve sat with benefits teams who spend months negotiating a tight specialty network, only to watch phantom referral patterns drive claims right back into the open PPO tier. The telehealth app, innocent as it seems, quietly unravels that work one referral at a time.
When Compliance Gets Expensive
Then there’s the legal layer. Selecting a telehealth vendor is an ERISA fiduciary act. Plan sponsors are responsible for monitoring reasonableness of fees and quality of services. If your contract doesn’t include performance guarantees around downstream utilization-and most don’t-you could be looking at a fiduciary breach claim down the road if the vendor’s practices are later shown to have inflated total health spend.
The No Surprises Act applies to certain telemedicine services, and the Consolidated Appropriations Act’s transparency rules require every telehealth claim to be included in the annual Rx and health care spending submission. A fragmented vendor that delivers messy, inconsistent data can leave your benefits team scrambling at compliance deadlines-and potentially facing fines.
A Better Way to Build Virtual Care
None of this means telemedicine should be stripped from the plan. It means we have to stop treating it like a stand-alone transaction and start embedding it inside a real care delivery strategy. Here’s what that looks like in practice, based on what I’ve seen work in the market:
- Tether virtual visits to the medical home. Whether through an advanced primary care model or a carrier-integrated telehealth service that shares the same EMR, the virtual encounter should be an extension of the patient’s primary care relationship-not a random walk-in clinic in the cloud. That keeps referrals inside steered networks and prevents redundant testing.
- Restore a modest cost-share. Align the copay or coinsurance for virtual visits with the rest of your benefit tier. If an in-person PCP visit is $25, telemedicine shouldn’t be zero. Pre-deductible coverage can be reserved for chronic care follow-ups and preventive check-ins, not for episodic acute care.
- Measure total cost per episode. Stop tracking per-visit savings. Build a dashboard that follows every telemedicine claim for 30, 60, and 90 days, capturing all pharmacy, lab, imaging, and specialist spend. Compare that episode cost against matched members who started care in person. That’s the number that matters.
- Make it part of the member’s digital front door. Instead of promoting a separate app, embed telemedicine alongside in-network provider search, cost estimators, and health risk assessments. When a member looks up a symptom, guide them to the highest-value entry point-which might be a virtual visit with their own PCP, an e-visit, or a nurse triage line-rather than defaulting them to a third-party urgent care app.
The plans I’ve seen achieve real results aren’t asking “How much can we save per virtual visit?” They’re asking a sharper question: “How do we build a connected experience where the right care lands in the right channel at the right cost?” Answering that means tearing down the wall between telemedicine and everything else. Because the real comparison isn’t virtual versus in-person care. It’s fragmented convenience versus integrated value.